Post-Operative Therapy for Nausea or Vomiting
Primary Purpose
Vomiting, Nausea
Status
Terminated
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
Acupressure
Ondansetron
Sponsored by
About this trial
This is an interventional treatment trial for Vomiting focused on measuring PONV, Nausea, Vomiting, Acupressure
Eligibility Criteria
Inclusion Criteria:
- Patients scheduled for elective surgery requiring general anesthesia
Exclusion Criteria:
- Age less than 18 years
- Adults unable to give primary consent
- Pregnancy
- Prisoners
- Unable to access pericardial 6 acupressure point bilaterally post procedure
- Allergy to Ondansetron
Sites / Locations
- UC Davis Health
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Acupressure
Ondansetron
Arm Description
Manual pressure will be applied on the wrists bilaterally.
Ondansetron (Zofran) is used for the treatment of nausea and vomiting.
Outcomes
Primary Outcome Measures
Change in Nausea Score
Difference in the nausea score before and after treatment. Nausea is scored on a scale from 1 to 10 with 1 being no nausea and 10 being severe nausea with impending vomiting.
A greater difference is indicative of a better outcome
Secondary Outcome Measures
Full Information
NCT ID
NCT03075163
First Posted
January 11, 2017
Last Updated
June 4, 2019
Sponsor
University of California, Davis
1. Study Identification
Unique Protocol Identification Number
NCT03075163
Brief Title
Post-Operative Therapy for Nausea or Vomiting
Official Title
Optimization of Post-Operative Therapy for Nausea or Vomiting
Study Type
Interventional
2. Study Status
Record Verification Date
June 2019
Overall Recruitment Status
Terminated
Why Stopped
recruitment futility
Study Start Date
October 18, 2016 (Actual)
Primary Completion Date
April 2017 (Actual)
Study Completion Date
December 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of California, Davis
4. Oversight
Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This is a single site, prospective, randomized controlled study designed to evaluate the impact of acupressure when used as an initial treatment before rescue medications in the treatment of post-operative nausea and/or vomiting at UCD.
Detailed Description
Each individual will only participate in the post anesthetic care unit starting from when the patient's nurse or anesthesiology team deems that the patient needs treatment for PONV. It ends when the patient is discharged from anesthesiology care.
Patients will be asked to score nausea before randomized treatment of acupressure or medication, and to score nausea after treatment.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Vomiting, Nausea
Keywords
PONV, Nausea, Vomiting, Acupressure
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
300 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Acupressure
Arm Type
Experimental
Arm Description
Manual pressure will be applied on the wrists bilaterally.
Arm Title
Ondansetron
Arm Type
Active Comparator
Arm Description
Ondansetron (Zofran) is used for the treatment of nausea and vomiting.
Intervention Type
Procedure
Intervention Name(s)
Acupressure
Intervention Description
Specifically trained personnel will apply pressure on the wrists bilaterally at the P6 point for up to 3 minutes. The P6 point is located three fingerbreadths from the wrist crease on the volar surface of the arm between the palmaris longus and flexor carpi radialis.
In the event of failure in the acupressure group, further treatments will be identical to the control group. Since Ondansetron is the standard Post Anesthetic Care Unit treatment, it will be first line rescue therapy except in the case that the patient has received 8mg in the past 6 hours. If needed, further antiemetic pharmacologic treatments may include, but are not limited to, phenergan, metoclopramide, haloperidol, diphenhydramine or propofol at the clinical discretion of the patient's anesthesiology care team.
Intervention Type
Drug
Intervention Name(s)
Ondansetron
Other Intervention Name(s)
Zofran
Intervention Description
Ondansetron is a medication that belongs to the drug class known as antiemetic and selective 5-HT3 receptor antagonist. Ondansetron is prescribed for the treatment of nausea and vomiting due to cancer chemotherapy and also used to prevent and treat nausea and vomiting after surgery.
Primary Outcome Measure Information:
Title
Change in Nausea Score
Description
Difference in the nausea score before and after treatment. Nausea is scored on a scale from 1 to 10 with 1 being no nausea and 10 being severe nausea with impending vomiting.
A greater difference is indicative of a better outcome
Time Frame
Time to discharge from post anesthetic care unit
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
- Patients scheduled for elective surgery requiring general anesthesia
Exclusion Criteria:
Age less than 18 years
Adults unable to give primary consent
Pregnancy
Prisoners
Unable to access pericardial 6 acupressure point bilaterally post procedure
Allergy to Ondansetron
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Paul Marc, MD, PhD
Organizational Affiliation
University of CA, Davis
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Neal W Fleming, MD, PhD
Organizational Affiliation
University of CA, Davis
Official's Role
Principal Investigator
Facility Information:
Facility Name
UC Davis Health
City
Sacramento
State/Province
California
ZIP/Postal Code
95817
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
22223185
Citation
Parra-Sanchez I, Abdallah R, You J, Fu AZ, Grady M, Cummings K 3rd, Apfel C, Sessler DI. A time-motion economic analysis of postoperative nausea and vomiting in ambulatory surgery. Can J Anaesth. 2012 Apr;59(4):366-75. doi: 10.1007/s12630-011-9660-x. Epub 2012 Jan 6.
Results Reference
background
PubMed Identifier
22156268
Citation
Chandrakantan A, Glass PS. Multimodal therapies for postoperative nausea and vomiting, and pain. Br J Anaesth. 2011 Dec;107 Suppl 1:i27-40. doi: 10.1093/bja/aer358.
Results Reference
background
PubMed Identifier
8129160
Citation
Hirsch J. Impact of postoperative nausea and vomiting in the surgical setting. Anaesthesia. 1994 Jan;49 Suppl:30-3. doi: 10.1111/j.1365-2044.1994.tb03580.x.
Results Reference
background
PubMed Identifier
18042859
Citation
Gan TJ, Meyer TA, Apfel CC, Chung F, Davis PJ, Habib AS, Hooper VD, Kovac AL, Kranke P, Myles P, Philip BK, Samsa G, Sessler DI, Temo J, Tramer MR, Vander Kolk C, Watcha M; Society for Ambulatory Anesthesia. Society for Ambulatory Anesthesia guidelines for the management of postoperative nausea and vomiting. Anesth Analg. 2007 Dec;105(6):1615-28, table of contents. doi: 10.1213/01.ane.0000295230.55439.f4.
Results Reference
background
PubMed Identifier
22504214
Citation
White PF, Zhao M, Tang J, Wender RH, Yumul R, Sloninsky AV, Naruse R, Kariger R, Cunneen S. Use of a disposable acupressure device as part of a multimodal antiemetic strategy for reducing postoperative nausea and vomiting. Anesth Analg. 2012 Jul;115(1):31-7. doi: 10.1213/ANE.0b013e3182536f27. Epub 2012 Apr 13.
Results Reference
background
PubMed Identifier
19370583
Citation
Lee A, Fan LT. Stimulation of the wrist acupuncture point P6 for preventing postoperative nausea and vomiting. Cochrane Database Syst Rev. 2009 Apr 15;(2):CD003281. doi: 10.1002/14651858.CD003281.pub3.
Results Reference
background
PubMed Identifier
21169634
Citation
Liodden I, Howley M, Grimsgaard AS, Fonnebo VM, Borud EK, Alraek T, Norheim AJ. Perioperative acupuncture and postoperative acupressure can prevent postoperative vomiting following paediatric tonsillectomy or adenoidectomy: a pragmatic randomised controlled trial. Acupunct Med. 2011 Mar;29(1):9-15. doi: 10.1136/aim.2010.002915. Epub 2010 Dec 18.
Results Reference
background
PubMed Identifier
22950829
Citation
Alessandrini M, Napolitano B, Micarelli A, de Padova A, Bruno E. P6 acupressure effectiveness on acute vertiginous patients: a double blind randomized study. J Altern Complement Med. 2012 Dec;18(12):1121-6. doi: 10.1089/acm.2011.0384. Epub 2012 Sep 5.
Results Reference
background
PubMed Identifier
23605600
Citation
Noroozinia H, Mahoori A, Hasani E, Gerami-Fahim M, Sepehrvand N. The effect of acupressure on nausea and vomiting after cesarean section under spinal anesthesia. Acta Med Iran. 2013 Apr 6;51(3):163-7.
Results Reference
background
PubMed Identifier
24787745
Citation
Genc F, Tan M. The effect of acupressure application on chemotherapy-induced nausea, vomiting, and anxiety in patients with breast cancer. Palliat Support Care. 2015 Apr;13(2):275-84. doi: 10.1017/S1478951514000248. Epub 2014 Apr 30.
Results Reference
background
PubMed Identifier
15844844
Citation
Huang ST, Chen GY, Lo HM, Lin JG, Lee YS, Kuo CD. Increase in the vagal modulation by acupuncture at neiguan point in the healthy subjects. Am J Chin Med. 2005;33(1):157-64. doi: 10.1142/S0192415X0500276X.
Results Reference
background
PubMed Identifier
15934175
Citation
Tokumaru O, Chen JD. Effects of acupressure on gastric myoelectrical activity in healthy humans. Scand J Gastroenterol. 2005 Mar;40(3):319-25. doi: 10.1080/00365520410009636.
Results Reference
background
Links:
URL
https://medlineplus.gov/druginfo/meds/a601209.html
Description
Ondansetron
Learn more about this trial
Post-Operative Therapy for Nausea or Vomiting
We'll reach out to this number within 24 hrs